SCHEMBL7974083

SCHEMBL7974083

O=c1nc(-c2ccccc2)[nH]c2ncn(Cc3ccccc3Cl)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 2/20 0.43
PARN O95453 1/20 0.43
CNOT7 Q9UIV1 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
ROCK2 O75116 1/20 0.39
KDM4E B2RXH2 1/20 0.39
P2RX7 Q99572 3/20 0.39
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985428 0.89 SMN1; SMN2 (0.41) ACP1PARNCNOT7ALDH1A1MEN1
SCHEMBL7975271 0.87 CNOT7 (0.56) PARNCNOT7ALDH1A1KMT2ASMN1; SMN2
SCHEMBL7984791 0.86 SMN1; SMN2 (0.45) PARNCNOT7ALDH1A1MEN1KMT2A
SCHEMBL7987224 0.86 LMNA (0.44) PARNCNOT7ALDH1A1MEN1KMT2A
SCHEMBL7991406 0.85 CNOT7 (0.49) ACP1PARNCNOT7ALDH1A1MEN1
SCHEMBL7984461 0.82 CNOT7 (0.52) ACP1PARNCNOT7ALDH1A1KMT2A
SCHEMBL7984720 0.81 CNOT7 (0.48) ACP1PARNCNOT7ALDH1A1LMNA
SCHEMBL7974079 0.81 ALDH1A1 (0.47) ACP1ALDH1A1MEN1KMT2AROCK2
SCHEMBL7986522 0.81 CNOT7 (0.48) ACP1PARNCNOT7ALDH1A1MEN1
SCHEMBL7988669 0.81 PARN (0.48) ACP1PARNCNOT7ALDH1A1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed